Log In
Print
BCIQ
Print
Print this Print this
 

BAY41-6551, NKTR-061, Amikacin Inhale

  Manage Alerts
Collapse Summary General Information
Company Nektar Therapeutics
DescriptionSecond-generation nebulizer delivery of amikacin
Molecular Target Ribosomal 30S subunit
Mechanism of ActionRibosomal 30S subunit inhibitor
Latest Stage of DevelopmentPhase III
IndicationPneumonia
Partner

Bayer AG
 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today